The Challenges of Developing an API Crystallization Process for a Complex Polymorphic and Highly Solvating System. Part I
Citations Over TimeTop 18% of 2009 papers
Abstract
Developing a robust crystallization process for an active pharmaceutical ingredient (API) molecule with a complex polymorphic profile can present a significant challenge. The presented case illustrates an unusual crystallization development problem where a polymorphically complex API has the additional obstacles of poor solubility in standard crystallization solvents as well as a propensity for forming solvates. After early polymorph screening of this candidate highlighted the potential for a complex solid form profile, a variety of experimental approaches was utilized to determine the low-energy polymorph and characterize the various solvates formed. Characterization of the API crystallization process identified a critical solvent composition range for the transformation from a metastable solvate form to the desired polymorph. During subsequent crystallization process development studies, a new lower-energy polymorph was discovered. Examination of the crystal structures led to a rationale for the formation of solvates and the existence of a new lower-energy form.
Related Papers
- → Crystallization and Polymorphism of Conformationally Flexible Molecules: Problems, Patterns, and Strategies(2000)188 cited
- → Rich polymorphism in nicotinamide revealed by melt crystallization and crystal structure prediction(2020)58 cited
- → Controlling Polymorphism by Crystallization on Self-Assembled Multilayers(2007)35 cited
- → Polymorphism of cyanoadamantane crystal(2003)
- SELECTIVE STABILIZATION BY ADDITION OF THE LIGHT HYDROGEN ISOTOPE(2014)